PYXS
Pyxis Oncology Inc
2.30$
-19.7%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | +0.0% | +38.0% | +9.6% | +171.8% | +54.7% | +51.3% | |
| – | +57.1% | +14,538.6% | +144.7% | +7.5% | -23.6% | -8.8% | |
| – | -142.9% | – | -51.8% | – | – | – | |
| – | +352.9% | +191.9% | -32.6% | -359.1% | – | – | |
| – | +0.0% | -63.6% | +1,085.0% | +5.1% | -96.5% | -96.2% | |
| – | +0.0% | -60.2% | +984.6% | +1,538.5% | – | +621.7% | |
| – | – | – | -99.9% | -100.2% | – | – | |
| – | -99.8% | +868,597.1% | -99.9% | +3,139.9% | +900.6% | -99.0% | |
| – | -158.5% | – | -135.6% | – | – | -141.3% | |
| – | – | – | – | – | – | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.